Type 2 & other diabetes

Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease

Diabetes CarePublished Cross-sectional study

Authors' conclusion

Hyperglucagonemia in the face of higher HLC in early T2D is not due to differences in insulin sensitivity or glucagonotropic metabolites but could suggest hepatic glucagon resistance.

Study context

Population
Individuals with newly diagnosed T2D and matched individuals with normal glucose tolerance (NGT); mixed-meal tolerance tests, hyperinsulinemic-euglycemic clamps, indirect calorimetry, 1H/31P MR spectroscopy and MRI
Participants
50 vs 50
Exposure
Newly diagnosed T2D vs normal glucose tolerance
  • T2Dn = 50
  • NGTn = 50reference
Outcome
HLC and fasting and postprandial glucagonemia
Methodological detailsage-, sex- and BMI-matched
  • Age-, sex- and BMI-matched

Main finding

As reported in the abstract

Higher hepatic lipid content (HLC) with T2D vs NGT

∼65%

Higher fasting glucagonemia with T2D vs NGT

∼30%

Higher postprandial glucagonemia with T2D vs NGT

∼75%

Postprandial glucagon related to HLC only in T2D; higher early postprandial glucagonemia with combined MASLD and T2D

∼47%

Observational data: associations, not effects.

Original publication

Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease. Diabetes Care. Published 2 April 2026. doi:10.2337/dc25-3077

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.